Publications by authors named "Simon Buus"

Claim this Profile
C
Cross-dataset pan-cancer detection by correlating cell-free DNA fragment coverage with open chromatin sites across cell types.
Ludvig Renbo Olsen, Denis Odinokov, Jakob Qvortrup Holsting, Karoline Kondrup, Laura Iisager, Simon Buus

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cone-beam CT-based estimations of prostate motion and dose distortion during radiotherapy.
Karolina A Klucznik, Thomas Ravkilde, Simon Skouboe, Ditte S Møller, Steffen Hokland, Simon Buus

Phys Imaging Radiat Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying dose perturbations in high-risk prostate radiotherapy due to translational and rotational motion of prostate and pelvic lymph nodes.
Karolina A Klucznik, Thomas Ravkilde, Simon Skouboe, Ditte S Møller, Steffen B Hokland, Simon Buus

Med Phys· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo dosimetry with an inorganic scintillation detector during multi-channel vaginal cylinder pulsed dose-rate brachytherapy: Dosimetry for pulsed dose-rate brachytherapy.
Peter D Georgi, Søren K Nielsen, Anders T Hansen, Harald Spejlborg, Susanne Rylander, Simon Buus

Phys Imaging Radiat Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes using a 3D printed tandem-needle-template and the EMBRACE-II planning aims for image guided adaptive brachytherapy in locally advanced cervical cancer.
Anne Cobussen, Primoz Petric, Christian Nielsen Wulff, Simon Buus, Harald Spejlborg

Acta Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D dose reconstruction based on in vivo dosimetry for determining the dosimetric impact of geometric variations in high-dose-rate prostate brachytherapy.
Erik B Jørgensen, Simon Buus, Lise Bentzen, Steffen B Hokland, Susanne Rylander

Radiother Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen deprivation therapy and cognitive decline-associations with brain connectomes, endocrine status, and risk genotypes.
Cecilie R Buskbjerg, Ali Amidi, Simon Buus, Claus H Gravholt, S M Hadi Hosseini

Prostate Cancer Prostatic Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive impairment and associations with structural brain networks, endocrine status, and risk genotypes in patients with newly diagnosed prostate cancer referred to androgen-deprivation therapy.
Cecilie R Buskbjerg, Robert Zachariae, Simon Buus, Claus H Gravholt, Lene Haldbo-Classen

Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of an in vivo dosimetry-based source tracking method for afterloading brachytherapy - A phantom study.
Erik B Jørgensen, Gustavo Kertzscher, Simon Buus, Lise Bentzen, Steffen B Hokland

Med Phys· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer evaluated by repeated MRI.
Simon Buus, Maria Lizondo, Steffen Hokland, Susanne Rylander, Erik M Pedersen

Brachytherapy· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-resolved in vivo dosimetry for source tracking in brachytherapy.
Jacob Graversen Johansen, Susanne Rylander, Simon Buus, Lise Bentzen, Steffen Bjerre Hokland

Brachytherapy· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vertebral Myeloma Mimicking Prostatic Carcinoma Metastasis in 68Ga-PSMA PET/CT.
Esben Hoej Merrild, Steen Baerentzen, Kirsten Bouchelouche, Simon Buus

Clin Nucl Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Learning curve of MRI-based planning for high-dose-rate brachytherapy for prostate cancer.
Simon Buus, Susanne Rylander, Steffen Hokland, Christian Skou Søndergaard, Erik Morre Pedersen

Brachytherapy· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetric impact of contouring and needle reconstruction uncertainties in US-, CT- and MRI-based high-dose-rate prostate brachytherapy treatment planning.
Susanne Rylander, Simon Buus, Erik M Pedersen, Lise Bentzen, Kari Tanderup

Radiother Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of a rectal ultrasound probe on the separation between prostate and rectum in high-dose-rate brachytherapy.
Susanne Rylander, Simon Buus, Lise Bentzen, Erik Morre Pedersen, Kari Tanderup

Brachytherapy· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode.
Lise Saksø Mortensen, Simon Buus, Marianne Nordsmark, Lise Bentzen, Ole Lajord Munk

Acta Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study.
Jørgen Johansen, Simon Buus, Annika Loft, Susanne Keiding, Marie Overgaard

Head Neck· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individual radiation response of parotid glands investigated by dynamic 11C-methionine PET.
Simon Buus, Cai Grau, Ole Lajord Munk, Anders Rodell, Kenneth Jensen

Radiother Oncol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.
Martin Hutchings, Annika Loft, Mads Hansen, Lars Møller Pedersen, Thora Buhl, Simon Buus

Blood· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
11C-methionine PET, a novel method for measuring regional salivary gland function after radiotherapy of head and neck cancer.
Simon Buus, Cai Grau, Ole Lajord Munk, Dirk Bender, Kenneth Jensen

Radiother Oncol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis